OCCIDENT

OCCIDENT

Wagniskapital- und Private-Equity-Auftraggeber

München, BY 2.400 Follower:innen

OCCIDENT – The Science Investor.

Info

OCCIDENT investiert in Deep-Tech-Startups mit dem Fokus auf Spin-offs aus der wissenschaftlichen Forschung, hat damit tatsächlichen Impact und ermöglicht konkrete Lösungen für unterschiedliche gesellschaftliche Herausforderungen. Als eigentümergeführter Venture Capital Investor mit Standorten in München und Zug unterstützt OCCIDENT Startups aus den Bereichen Lifesciences und Industrial Tech ab der Seed-Finanzierungsrunde, begleitet seine Portfoliounternehmen langfristig sowohl finanziell als auch mit seiner umfassenden Erfahrung, und ermöglicht Gründer:innenteams damit, Herausragendes zu leisten. Mit einer starken unternehmerischen Denkweise investiert OCCIDENT eigenes Geld und trifft Entscheidungen unter Berücksichtigung des nachhaltigen Erfolgspotenzials. Die Zusammenarbeit mit den Gründer:innenteams seiner Portfoliounternehmen spornt das OCCIDENT Team jeden Tag aufs Neue an. Deren Leidenschaft und Tatkraft inspiriert, der vielfach sehr intensive Austausch motiviert, Herausforderungen gemeinsam anzupacken. OCCIDENTs Anspruch bei jedem seiner Investments ist es, nachhaltig einen positiven Beitrag für die Gesellschaft zu leisten.

Website
https://www.occident.group
Branche
Wagniskapital- und Private-Equity-Auftraggeber
Größe
2–10 Beschäftigte
Hauptsitz
München, BY
Art
Kapitalgesellschaft (AG, GmbH, UG etc.)
Gegründet
2014
Spezialgebiete
Industrial Tech, Life Sciences, Deep Tech, Science Investor, Entrepreneurial Investor, Biotech, Pharma, Diagnostics, MedTech, HealthTech, Chemistry, Manufacturing, ClimateTech, Robotics, IIoT, Semiconductor, Photonics, Optics, New Materials, New Space, Quantum Technologies, Industrial Biotech und Veterinary Medicine

Orte

Beschäftigte von OCCIDENT

Updates

  • OCCIDENT hat dies direkt geteilt

    Unternehmensseite von Algiax Pharmaceuticals anzeigen, Grafik

    663 Follower:innen

    Algiax Pharmaceuticals GmbH Announces Completion of Patient Enrollment in Phase 2 Clinical Trial in Chronic Neuropathic Pain Check out the full press release here: https://lnkd.in/ec9wy9dS Thrilled to share that Algiax Pharmaceuticals participates at #BIOEurope in Stockholm and the #JefferiesHealthcare Conference. These events are fantastic opportunities to meet our CEO Ingo Lehrke to update you on our completion of patient enrollment in our Phase 2 trial for chronic neuropathic pain and next steps.

    • Kein Alt-Text für dieses Bild vorhanden
  • Unternehmensseite von OCCIDENT anzeigen, Grafik

    2.400 Follower:innen

    𝗘𝘅𝗰𝗶𝘁𝗶𝗻𝗴 𝗻𝗲𝘄𝘀 𝗳𝗿𝗼𝗺 𝗼𝘂𝗿 𝗽𝗼𝗿𝘁𝗳𝗼𝗹𝗶𝗼 𝗰𝗼𝗺𝗽𝗮𝗻𝘆 𝗥𝗲𝗖𝗮𝘁𝗮𝗹𝘆𝘀𝘁   The company has recently achieved 𝘁𝗵𝗿𝗲𝗲 𝘀𝗶𝗴𝗻𝗶𝗳𝗶𝗰𝗮𝗻𝘁 𝗺𝗶𝗹𝗲𝘀𝘁𝗼𝗻𝗲𝘀 that highlight their rapid growth and innovation in the hydrogen fuel cell market:   First, 𝗠𝗲𝗺𝗼𝗿𝗮𝗻𝗱𝘂𝗺 𝗼𝗳 𝗨𝗻𝗱𝗲𝗿𝘀𝘁𝗮𝗻𝗱𝗶𝗻𝗴: ReCatalyst signed its first MoU with a Membrane Electrode Assembly (MEA) producer. This crucial agreement demonstrates the market potential of the next-generation platinum alloy catalysts for PEM fuel cells and sets the stage for formal commercial agreements that align perfectly with the mission to enable mass market adoption of PEM fuel cell vehicles through optimized precious metal usage.   Second, 𝗴𝗿𝗼𝘂𝗻𝗱𝗯𝗿𝗲𝗮𝗸𝗶𝗻𝗴 𝗰𝗮𝘁𝗮𝗹𝘆𝘀𝘁 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻: This fall, the company unveiled a new fuel cell catalyst product based on highly accessible mesoporous carbon supports. This innovative design addresses critical challenges in fuel cell technology by improving the accessibility of platinum-based nanoparticles to reactants, which could significantly enhance overall fuel cell performance. This development is in line with industry trends, following Toyota's successful integration of similar technology into its second-generation Mirai hydrogen fuel cell vehicle.   Third, 𝘀𝘂𝗰𝗰𝗲𝘀𝘀𝗳𝘂𝗹 𝗽𝗿𝗼𝗱𝘂𝗰𝘁 𝗹𝗮𝘂𝗻𝗰𝗵: Following the impressive product release, the first limited series of next-generation platinum alloy mesoporous carbon catalysts has already sold out with product deliveries underway. This rapid market uptake underscores the strong demand for the next generation.   Overall, these achievements demonstrate ReCatalyst's growing influence in the fuel cell industry. Congratulations to the entire team for these well recognized successes!   Matija Gatalo, Tomaz Bizjak, Javier Gonzalez Lopez, Jerneja (Nej) Loncar, Teo Velikonja, Aleksandra Logar, Martin Petric, Luka Pavko, Matej Š., Tina Černič, Jošt Oblak, Žiga Ponikvar #catalysts #electrocatalysts #hydrogen #fuelcells #decarbonization #sustainability #nanotech

    • Kein Alt-Text für dieses Bild vorhanden
  • Unternehmensseite von OCCIDENT anzeigen, Grafik

    2.400 Follower:innen

    𝗠𝗘𝗘𝗧 𝗢𝗖𝗖𝗜𝗗𝗘𝗡𝗧 𝗶𝗻 𝗡𝗼𝘃𝗲𝗺𝗯𝗲𝗿   📍Munich: Meet Michael, Simon and Paul on November 5 at the exclusive OCCIDENT pitch session as part of Venturelab’s 𝗩𝗲𝗻𝘁𝘂𝗿𝗲 𝗟𝗲𝗮𝗱𝗲𝗿𝘀 𝗖𝗹𝗲𝗮𝗻𝘁𝗲𝗰𝗵 𝗥𝗼𝗮𝗱𝘀𝗵𝗼𝘄.   The investor and business development roadshow to Munich provides the 10 most promising cleantech start-ups from Switzerland a deep insight into the international start-up ecosystem.     📍Zurich: Meet Mirco at the 𝗪𝘆𝘀𝘀 𝗭𝘂𝗿𝗶𝗰𝗵 𝗔𝗻𝗻𝘂𝗮𝗹 𝗘𝘃𝗲𝗻𝘁 on November 6.   The Wyss Zurich Translational Center is a unique accelerator, dedicated to the emerging fields of regenerative medicine, robotics and medical devices.     📍Breisach/Online: Meet Cédric at the 5th edition of the 𝗧𝗿𝗶𝗻𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗛𝗲𝗮𝗹𝘁𝗵𝗧𝗲𝗰𝗵 𝗗𝗮𝘆𝘀on November 7 and 8.   The Trinational HealthTech Days aim to connect innovative start-ups and the ecosystems from France, Germany and Switzerland to promote international cooperation in the health technology sector (biotech, medtech, digital health). More: https://lnkd.in/eJEh_MK     📍Leipzig: Meet Simon and Paul at the 𝗩𝗖 𝗟𝘂𝗻𝗰𝗵 𝗠𝗶𝘁𝘁𝗲𝗹𝗱𝗲𝘂𝘁𝘀𝗰𝗵𝗹𝗮𝗻𝗱 on November 12.   This get-together for VCs, CVCs and Business Angels is hosted by OCCIDENT, SpinLab - The HHL Accelerator, HTGF | High-Tech Gründerfonds and Smart Infrastructure Ventures ('SIVentures').     📍Munich: Meet Cédric and Paul at the𝗕𝗮𝘆𝗦𝘁𝗮𝗿𝘁𝗨𝗣 𝘅 𝗕𝗶𝗼𝗠 𝗣𝗶𝘁𝗰𝗵 𝗗𝗮𝘆 on November 14.   We are looking forward to meeting innovative Bavarian start-ups from the life sciences sector from one of Bavaria’s strongest incubators.     📍Magdeburg: Meet Simon and Cédric at the 𝗶𝗻𝘃𝗲𝘀𝘁𝗳𝗼𝗿𝘂𝗺 𝗽𝗶𝘁𝗰𝗵 𝗱𝗮𝘆 𝟮𝟬𝟮𝟰 on November 19.   This pitch event is the biggest event of the year for the start-up scene in Saxony-Anhalt – we very much look forward to participating. More: https://lnkd.in/ewgCDENK     📍Munich: Meet Cédric, Mirco and Paul at the 𝗗𝗶𝗴𝗶𝘁𝗮𝗹 𝗛𝗲𝗮𝗹𝘁𝗵 𝗣𝗶𝘁𝗰𝗵 𝗗𝗮𝘆 𝟮𝟬𝟮𝟰 hosted by @HTGF on November 28.   The Digital Health Pitch Day offers an exciting opportunity to get in touch with relevant industry players, meet other VCs and hear pitches from digital health start-ups. More: https://lnkd.in/g2JsR-g2     #deeptech #venturecapital #investment #startups #founder #investor #spinoffs #technology #innovation

    • Kein Alt-Text für dieses Bild vorhanden
  • Unternehmensseite von OCCIDENT anzeigen, Grafik

    2.400 Follower:innen

    𝗧𝗵𝗮𝗻𝗸 𝘆𝗼𝘂 𝗠𝗔𝗫!𝗶𝗺𝗶𝘇𝗲 𝗳𝗼𝗿 𝗼𝗿𝗴𝗮𝗻𝗶𝘇𝗶𝗻𝗴 𝘆𝗲𝘀𝘁𝗲𝗿𝗱𝗮𝘆'𝘀 𝗩𝗖 𝗙𝗿𝗶𝗲𝗻𝗱𝗹𝘆 𝗙𝗲𝗲𝗱𝗯𝗮𝗰𝗸 𝗦𝗲𝘀𝘀𝗶𝗼𝗻 It was a great opportunity for early-stage start-ups to prepare for future funding rounds. Our investment manager Paul Sunzenauer was happy to provide expert mentoring to innovative founders together with other selected VCs. At OCCIDENT, we are always keen to engage with founders at an early stage, long before we invest. We believe this is mutually beneficial and underlines our role as a long-term enabler. As a science investor, we support founders with our expertise and network from an early stage to build their investment case and stand out from the crowd. In the dynamic world of entrepreneurship, the ability to deliver a compelling business pitch can significantly impact the success story of a start-up. Pitching to investors at a nascent stage is crucial to get early feedback, and this may be particularly true for scientific deep-tech start-ups. Even the best data is not enough to sell a business case! Being able to communicate a vision convincingly is one of the most important skills for start-up founders. If you can excite investors early on, you will be able to excite customers, strategic partners and other stakeholders later on. We hope this event has offered some valuable insights and we are always happy to connect with founders and offer our mentoring. Thank you Kathrin Schelbaum and Sarah Oppenländer for the organization! #lifesciences #biotech #pharma #startups #spinoffs #founders #investors #venturecapital #pitch #pitchdeck

    • Kein Alt-Text für dieses Bild vorhanden
  • OCCIDENT hat dies direkt geteilt

    Unternehmensseite von MAX!mize incubator for Max Planck start-ups anzeigen, Grafik

    1.073 Follower:innen

    📋 "𝗔𝘀 𝗮 𝘃𝗲𝗻𝘁𝘂𝗿𝗲 𝗰𝗮𝗽𝗶𝘁𝗮𝗹𝗶𝘀𝘁, 𝘄𝗵𝗮𝘁 𝗾𝘂𝗲𝘀𝘁𝗶𝗼𝗻 𝗱𝗼 𝘆𝗼𝘂 𝗹𝗶𝗸𝗲 𝘁𝗼 𝗮𝘀𝗸 𝗮 𝘁𝗲𝗮𝗺?" We asked Christoph Wirth and Paul Sunzenauer this question regarding our upcoming Check-in. During the VC Friendly Feedback Session, they will give our MAX!mize start-ups feedback on their pitches and ask them questions, togehter with Carlotta Ficorella. A valuable opportunity for the teams to put their #business idea to the test, prepare for real VC rounds and expand their business #network. We are very much looking forward to welcoming the jury and would like to thank them in advance for their time and expertise. ➡️ Did you expect the questions and what would your start-up answer? 🧡 You are a Max Planck #scientist and want to turn your basic #research into business? Would you like to benefit from all the valuable services of our start-up incubation program? Then apply now for Batch #5: https://lnkd.in/gC8VvVJT #maximizeincubator is the official start-up #incubation program for the Max Planck Society by Max-Planck-Innovation GmbH.

  • Unternehmensseite von OCCIDENT anzeigen, Grafik

    2.400 Follower:innen

    🔬 Thank you for an inspiring 𝗟𝗶𝗳𝗲 𝗦𝗰𝗶𝗲𝗻𝗰𝗲 𝗜𝗻𝘃𝗲𝘀𝘁𝗼𝗿𝘀' 𝗗𝗮𝘆 𝗶𝗻 𝗛𝗲𝗶𝗱𝗲𝗹𝗯𝗲𝗿𝗴 It was great pleasure for Paul from OCCIDENT participating at the Life Science Investors' Day in Heidelberg, organized by BioLabs Heidelberg, BioRN Life Science Cluster Rhine-Neckar, Heidelberg Startup Partners e.V. and the Life Science Accelerator Baden-Württemberg. The event featured an impressive lineup of startups working on innovative therapies and technologies, all with the goal of improving patients' lives through breakthrough science. It was also a great opportunity to network with the industry and fellow investors. OCCIDENT is proud to support 𝗕𝗶𝗼𝗥𝗡 and to play an active role in this ecosystem. We are delighted to take on this role as a science investor and support transformative innovation in the life sciences. Many thanks to the entire organizing team for putting on such an inspiring event. We are already looking forward to the next Investors’ Day! More: https://lnkd.in/excnm3eP   Daniela Weber HTGF | High-Tech Gründerfonds BIOPRO Baden-Württemberg GmbH   #lifesciences #biotech #pharma #startups #spinoffs #founders #investors #venturecapital

    • Kein Alt-Text für dieses Bild vorhanden
  • Unternehmensseite von OCCIDENT anzeigen, Grafik

    2.400 Follower:innen

    𝗧𝗵𝗮𝗻𝗸 𝘆𝗼𝘂 𝗳𝗼𝗿 𝗳𝗮𝗯𝘂𝗹𝗼𝘂𝘀 HTVD | HIGHTECH VENTURE DAYS 𝟮𝟬𝟮𝟰!   OCCIDENT is proud sponsor of this high-profile event, where 40 of Europe's most innovative high-tech start-ups met with over 180 international investors and companies in Dresden. The gathering of almost the entire European deep-tech community left unforgettable impressions, countless new contacts and intensified existing relationships. Innovative pitches, interesting discussions and fruitful exchanges were rounded off by exclusive networking get-togethers such as the evening event at the Dresden Residence Palace or the Family Office Lunch.   As a long-standing supporter of this great event, OCCIDENT was represented by our investment manager Simon. Once again, our industrial tech portfolio was strongly represented at the HTVD | HIGHTECH VENTURE DAYS, with Markus Hessinger from core sensing GmbH, as well as ReCatalyst and Chipmetrics as HTVD alumni.   A big thank you to Alexander Tietze and the whole HTVD | HIGHTECH VENTURE DAYS team for the professional organization. We are already looking forward to supporting groundbreaking high-tech ventures with our esteemed partner HighTech Startbahn in 2025! #HTVD2024 #event #startups #spinoffs #founders #investors #venturecapital #hardware #industrialtech #deeptech #cleantech #energy #entrepreneurship #technology #innovation

    • Kein Alt-Text für dieses Bild vorhanden
    • Kein Alt-Text für dieses Bild vorhanden
    • Kein Alt-Text für dieses Bild vorhanden
    • Kein Alt-Text für dieses Bild vorhanden
  • Unternehmensseite von OCCIDENT anzeigen, Grafik

    2.400 Follower:innen

    𝗢𝗻𝗲 𝗼𝗳 OCCIDENT's 𝗘𝗺𝗽𝗹𝗼𝘆𝗲𝗲 𝗕𝗲𝗻𝗲𝗳𝗶𝘁𝘀: 𝗙𝗹𝗲𝘅 𝗢𝗳𝗳𝗶𝗰𝗲🌴💻   Starting the day with a walk on the beach? Enjoying a sundowner on the rooftop terrace in an exciting city after work? Or enjoying the warm weather elsewhere when it gets colder at home? You can have it all at OCCIDENT!   At OCCIDENT, we enjoy the opportunity to work from anywhere in the world for up to 15 days a year in addition to our annual vacation. As most of us love to travel, we enjoy the benefits this brings to us. It gives us the freedom and flexibility to set up our laptop anywhere in the world and explore new places for longer.   A road trip, during which you can advance your projects in between to reduce stress before and after your vacation, or an extended stay in the warm climate of the tropics are just two examples of how this flexible working model creates the perfect balance between work and relaxation.   At OCCIDENT, we believe that a supportive and flexible working environment is key to achieving outstanding results. With our location-independent flex office concept, we offer a modern working environment designed to make our employees happy and giving them the opportunity to enjoy some quality time away from the office routine.   #workfromanywhere #virtualoffice #flexoffice #remotework #employeebenefits #greatteam #greatplacetowork

    • Kein Alt-Text für dieses Bild vorhanden

Ähnliche Seiten

Jobs durchsuchen